Siolta Therapeutics is a developer of human microbiome therapeutics intended to prevent and treat inflammatory diseases. Founded in 2016, Siolta Therapeutics is backed by investors that include Global Brain Corporation, Marc Benioff, Khosla Ventures, Seventure Partners, and SymBiosis LLC and is headquartered in San Francisco.